Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.
about
C/EBPα deregulation as a paradigm for leukemogenesis.MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies.miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia.
P2860
Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.
@ast
Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.
@en
type
label
Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.
@ast
Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.
@en
prefLabel
Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.
@ast
Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.
@en
P2093
P2860
P50
P1476
Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation
@en
P2093
Anne-Marie Müller
Christiane Katzerke
Daniela Bräuer-Hartmann
Dennis Gerloff
Dietger Niederwieser
Gerhard Behre
Jens-Uwe Hartmann
Marius Bill
Meritxell Alberich-Jorda
Nadja Hilger
P2860
P2888
P356
10.1038/S41467-017-00032-6
P407
P577
2017-06-29T00:00:00Z
P6179
1090227578